Silence Therapeutics Plc (SLNCF)
3.85
-0.15
(-3.75%)
USD |
OTCM |
Oct 09, 16:00
Silence Therapeutics Free Cash Flow : -41.79M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -41.79M |
| March 31, 2026 | -66.18M |
| December 31, 2025 | -62.89M |
| September 30, 2025 | -71.25M |
| June 30, 2025 | -65.55M |
| March 31, 2025 | -51.86M |
| September 30, 2024 | -53.79M |
| Date | Value |
|---|---|
| June 30, 2024 | -34.27M |
| March 31, 2024 | -47.77M |
| December 31, 2023 | -47.77M |
| September 30, 2023 | -49.59M |
| June 30, 2023 | -55.19M |
| March 31, 2023 | -46.73M |
| December 31, 2022 | -56.93M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Biodexa Pharmaceuticals Plc | -10.63M |
| NuCana Plc | -6.612M |
| Mereo BioPharma Group Plc | -25.58M |
| Compass Pathways Plc | -160.76M |
| HemoGenyx Pharmaceuticals Plc | -1.937M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 1.548M |
| Cash from Investing (Quarterly) | 64.78M |
| Cash from Financing (Quarterly) | 0.002M |
| Free Cash Flow Per Share (Quarterly) | 0.0109 |
| Free Cash Flow to Equity (Quarterly) | 1.572M |
| Free Cash Flow to Firm (Quarterly) | 1.548M |
| Free Cash Flow Yield | -7.66% |